Cite
HARVARD Citation
Shao, H. et al. (2018). The impact of early molecular response in children and adolescents with chronic myeloid leukemia treated with imatinib: a single-center study from China. Leukemia & lymphoma. 59 (9), pp. 2152-2158. [Online].